跳至主要内容
临床试验/CTRI/2024/03/064745
CTRI/2024/03/064745尚未招募2 期

A Randomized Placebo Controlled Trial to evaluate the Effect of Takrabhaya Prayog in Metabolic Syndrome - NI

ational Institute of Ayurveda Jaipur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Individuals of 18 to 70 years of age of either sex.
  • Persons having history of sedentary life style and high calorie diet in daily routine.
  • Diagnosis of metabolic syndrome according the revised NCEP ATP III 2001 (National Cholesterol Education Programme Adult Treatment Panel III 2001) criteria; three or more of the following five criteria are met:
  • Waist circumference over 102 cm/40 inches (men) or 88 cm/35 inches (women),
  • Blood pressure over 130/85 mm Hg,
  • Fasting triglyceride level over 150 mg/dL,
  • Fasting high-density lipoprotein cholesterol level less than 40 mg/dL (men) or 50 mg/dL(women) and
  • Fasting blood sugar over 100 mg/dL.

排除标准

  • Smoking and alcohol intake
  • Any known acute or chronic hepatic, cardiac, respiratory, kidney or any systemic diseases.
  • Person Asatmya to Takra and Haritaki Churna(senstivity, allergy, difficulty in intake and lactose intolerance, etc)
  • Pregnancy and Lactation

研究者

发起方
ational Institute of Ayurveda Jaipur

相似试验